Home/Cellastra/Vinod Kumar, MD
VK

Vinod Kumar, MD

EVP, Chief Medical Officer

Cellastra

Cellastra Pipeline

DrugIndicationPhase
Anti-Scarring Gene Therapy PlatformPulmonary Fibrosis/Infections, Burn Injuries, Surgical Adhesions, Traumatic Brain InjuryPre-clinical